24
Oversold
Moving averages
SMA 200$1.50-75.35%
Company profile
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.
SectorHealthcare
IndustryBiotechnology
Market cap$90.02M
P/E ratioNone
EPS$-1.12
Beta1.054
Dividend yield0.00%
52-week high$2.62
52-week low$0.51
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
IMUX
Immunic Inc
RSI 45
SAVA
Cassava Sciences Inc
HRTX
Heron Therapeutics Inc
RSI 39
CGTX
Cognition Therapeutics Inc
RSI 29
NERV
Minerva Neurosciences Inc
RSI 36
IBIO
iBio Inc
RSI 52
RSI alerts for CHRS
An email when CHRS closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 3:22 AM EST